OKLO

Oklo

$71.00

-7.14%
Apr 24, 2026
Bobby Quantitative Model
Oklo Inc. is a pre-revenue nuclear energy company developing compact fission power plants, known as Aurora powerhouses, to provide clean, reliable, and affordable energy at scale. It operates as a disruptive technology developer in the regulated electric utility sector, aiming to commercialize its proprietary liquid metal fast reactor technology and offer used nuclear fuel recycling services. The current investor narrative is intensely focused on the company's progress toward commercialization, driven by recent key regulatory approvals, a landmark power purchase agreement with Meta, and validation from the White House's new space nuclear power initiative, which collectively underscore its potential but also highlight the significant execution risk and long timeline before revenue generation.

People also watch

NextEra Energy

NextEra Energy

NEE

Analysis
Southern Company

Southern Company

SO

Analysis
Duke Energy

Duke Energy

DUK

Analysis
American Electric Power

American Electric Power

AEP

Analysis
Dominion Energy

Dominion Energy

D

Analysis

BobbyInvestment Opinion: Should I buy OKLO Today?

Rating: Hold. The core thesis is that Oklo represents a high-risk, high-potential option on the future of advanced nuclear power, but its current valuation and extended timeline make it unsuitable for most investors outside of a highly speculative portfolio allocation.

Supporting this Hold rating are several data points: the stock trades at a speculative forward P/S of ~33.3x on distant revenue estimates, it has no traditional valuation anchor, and it is in a sustained technical downtrend (-59.11% over 6 months). Positively, it has a fortress balance sheet (Current Ratio: 49.08, D/E: 0.00098) and landmark commercial validation via the Meta PPA. However, the widening quarterly losses and -$115M TTM FCF burn underscore the immense execution risk.

The thesis would upgrade to a Buy only upon two conditions: 1) Securing the final, critical NRC license for commercial operation, and 2) a significant compression in valuation (e.g., market cap falling toward $5-6B) that better reflects the risk. It would downgrade to a Sell on a failed regulatory milestone, the cancellation of the Meta PPA, or a cash runway shrinking below 12 months without a clear funding path. Relative to its own short history and the complete absence of fundamentals, the stock is overvalued, pricing in near-perfect execution years in advance.

Sign up to view all

OKLO 12-Month Price Forecast

Oklo is a binary, option-like investment where the outcome will be determined by regulatory success and capital market patience over the next 3-5 years, not the next 12 months. The 12-month outlook is dominated by volatility around news flow, not fundamental change. The neutral stance reflects the offsetting forces of promising long-term optionality and punishing near-term financial reality. The stance would upgrade to bullish only on definitive, final regulatory approval for revenue-generating operations. It would downgrade to bearish on any indication the Meta deal is imperiled or the cash runway falls below one year without a clear path to funding.

Historical Price
Current Price $71
Average Target $65
High Target $150
Low Target $20

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Oklo's 12-month outlook, with a consensus price target around $92.30 and implied upside of +30.0% versus the current price.

Average Target

$92.30

6 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

6

covering this stock

Price Range

$57 - $92

Analyst target range

Buy
1 (17%)
Hold
3 (50%)
Sell
2 (33%)

Insufficient analyst coverage data is available in the provided dataset to calculate a consensus price target or recommendation distribution. The 'analyst_data' object contains only estimated EPS and revenue figures, not target prices or ratings. This lack of conventional analyst targets is typical for a recently listed, pre-revenue company in a highly specialized and long-duration industry like advanced nuclear power. The implications of limited coverage are significant: it often leads to higher stock price volatility and less efficient price discovery, as the investment thesis is not regularly vetted and debated by a broad analyst community. Investors must rely more heavily on company disclosures, regulatory milestones, and partnership announcements. The available institutional ratings data shows recent actions from several firms, including upgrades from B of A Securities and Seaport Global to 'Buy', indicating a building positive sentiment among the few covering analysts, but without specific price targets, the implied upside cannot be quantified.

Drowning in data?

Find the real signal!

Bulls vs Bears: OKLO Investment Factors

The bull case for Oklo is compelling but entirely forward-looking, built on massive market potential, strategic partnerships, and recent regulatory validation. The bear case is grounded in harsh present-day realities: zero revenue, steep losses, a high cash burn, and a valuation disconnected from fundamentals. Currently, the bearish evidence is stronger, as the stock's severe 6-month downtrend and complete lack of financial metrics outweigh the promising but distant catalysts. The single most important tension in the investment debate is the timing and certainty of commercialization: if Oklo secures final NRC approval and begins construction on schedule, the bull thesis validates; if delays mount or costs balloon, the current $10.5B valuation could collapse toward the $19.89 52-week low.

Bullish

  • Landmark PPA with Meta: The 6.6-gigawatt power purchase agreement with Meta provides critical long-term funding validation and a massive anchor customer for Oklo's future power plants. This deal directly addresses the AI industry's soaring energy demands and de-risks a significant portion of the company's future revenue stream.
  • Key Regulatory Progress: Recent critical regulatory approvals, including validation from the White House's space nuclear power initiative, position the company closer to its first commercial deployments. This progress reduces the binary risk of technology rejection by government bodies.
  • Strong Balance Sheet & Liquidity: With a current ratio of 49.08 and a debt-to-equity ratio of 0.00098, Oklo is virtually unleveraged and has ample liquidity to fund its development runway. The company raised $296.22 million in equity in Q4 2025, extending its cash runway significantly.
  • Massive Addressable Market Tailwind: The company operates in the high-demand, secular growth market of clean, reliable power for data centers and industrial applications. Geopolitical energy volatility and AI's power demands create a powerful tailwind for next-generation nuclear solutions.

Bearish

  • Pre-Revenue with No Near-Term Profitability: Oklo reported $0 revenue for Q4 2025 and a net loss of -$41.45 million, with losses widening sequentially. The company is in a pure development stage, with analyst estimates pointing to potential revenue only in the distant future (no timeline specified).
  • Extreme Valuation with No Fundamentals: The stock trades at a market cap of $10.5 billion with zero revenue, implying a speculative forward P/S of ~33.3x based on a distant $315.3M revenue estimate. The trailing P/B of 7.11x, while compressed from 13.92x, remains elevated for a pre-revenue company.
  • Severe Long-Term Price Downtrend: The stock is down 59.11% over the past six months and -29.64% over three months, trading at just 34.5% of its 52-week range. This sustained downtrend reflects deep investor skepticism and negative momentum despite recent positive news.
  • High Cash Burn with Long Timeline: The company burned -$115.38M in TTM free cash flow, with Q4 2025 FCF at -$60.38M. The path to commercialization is long, with news indicating revenue may not materialize until at least 2030, requiring continuous capital raises that dilute shareholders.

OKLO Technical Analysis

The prevailing price trend for Oklo is a pronounced and sustained downtrend from its post-listing highs, with the stock down 59.11% over the past six months. Despite this, the current price of $66.81 sits at just 34.5% of its 52-week range (between $19.89 and $193.84), indicating the stock is trading much closer to its 52-week low than its high, which suggests it may be in a deep value zone but also reflects severe negative momentum and investor skepticism. The 1-year price change of +203.96% is misleadingly positive, heavily skewed by the stock's initial public offering and subsequent volatility, while the more recent 3-month decline of -29.64% better captures the current bearish sentiment. Recent short-term momentum shows a potential inflection, with the stock up 17.83% over the past month, significantly outperforming the SPY's 7.36% gain. This positive 1-month relative strength of +10.47% suggests a potential short-term rebound or relief rally, possibly driven by recent positive news catalysts. However, this nascent uptick sharply conflicts with the longer-term 3-month and 6-month downtrends, signaling that while there may be a tactical bounce, it has not yet reversed the dominant bearish trend established over the last half-year. Key technical support is clearly defined at the 52-week low of $19.89, while resistance looms far above near the 52-week high of $193.84. A decisive breakout above the recent trading range would require a sustained move above the $70-$75 area, which could signal a trend reversal, while a breakdown below the $50 level could see a retest of the multi-month lows. With a beta of 0.943, the stock's volatility is slightly below that of the broader market, which is unusual for a pre-revenue speculative name and may indicate it is currently trading more on idiosyncratic company news than broad market movements.

Beta

0.94

0.94x market volatility

Max Drawdown

-73.8%

Largest decline past year

52-Week Range

$23-$194

Price range past year

Annual Return

+191.9%

Cumulative gain past year

PeriodOKLO ReturnS&P 500
1m+28.5%+8.7%
3m-19.0%+3.6%
6m-47.8%+5.4%
1y+191.9%+30.6%
ytd-8.7%+4.7%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

OKLO Fundamental Analysis

Oklo's revenue trajectory is non-existent, with quarterly revenue of $0 reported for Q4 2025 and every preceding quarter in the provided data. The company is in a pure pre-revenue development stage, with growth metrics currently inapplicable. The investment case is entirely forward-looking, hinging on the successful deployment of its first Aurora power plant, with analyst estimates pointing to potential revenue of $315.3 million in the future, though no timeline is specified in the data. The company is deeply unprofitable, reporting a net income of -$41.45 million and an EPS of -$0.27 for Q4 2025. Gross margin is 0%, and operating margin is also 0%, as there is no cost of goods sold against zero revenue; all expenses are classified as operating costs. The losses are substantial and have been widening sequentially, with net income deteriorating from -$9.81 million in Q1 2025 to -$41.45 million in Q4 2025, indicating the company is burning more cash as it advances its development efforts, moving further away from profitability in the near term. The balance sheet shows a strong liquidity position with a current ratio of 49.08, indicating ample short-term assets relative to liabilities, and a minimal debt-to-equity ratio of 0.00098, meaning the company is virtually unleveraged. However, cash flow is deeply negative, with operating cash flow of -$33.43 million and free cash flow of -$60.38 million for Q4 2025. The trailing twelve-month free cash flow is -$115.38 million, demonstrating a high cash burn rate that is funding operations and capital expenditures entirely through equity financing, as evidenced by the $296.22 million in common stock issued during the quarter.

Quarterly Revenue

$0.0B

2025-12

Revenue YoY Growth

N/A

YoY Comparison

Gross Margin

N/A

Latest Quarter

Free Cash Flow

$-115379000.0B

Last 12 Months

Open an Account, get $2 TSLA now!

Valuation Analysis: Is OKLO Overvalued?

Given that Net Income is deeply negative, the primary valuation metric selected is the Price-to-Sales (PS) ratio. However, the trailing PS ratio is 0 due to the absence of revenue. The forward-looking valuation is entirely speculative, based on analyst revenue estimates of $315.3 million, which would imply a forward PS ratio of approximately 33.3x based on the current market cap of $10.5 billion, though this is a rough estimate as the exact timing of that revenue is unknown. A peer comparison is challenging as the company has no revenue or profits, making standard multiples incomparable. The stock's market valuation of $10.5 billion reflects a premium for its first-mover potential in advanced nuclear and the optionality of its technology, rather than any current financial performance. This premium is not justified by traditional fundamentals but by the speculative potential of its business model and the massive addressable market for clean, reliable power, particularly for data centers and industrial applications. Historical context is limited due to the company's short public history, but the current trailing Price-to-Book (PB) ratio of 7.11x can be compared to its own historical range. This PB ratio is below the 13.92x seen in Q3 2025 but above the 2.97x from Q2 2024, indicating the valuation has compressed from recent highs but remains elevated compared to earlier periods. Trading near the middle of its own short PB history suggests the market has tempered some of its initial euphoria but still ascribes significant value to the company's equity, given its asset-light, IP-heavy business model.

PE

-99.4x

Latest Quarter

vs. Historical

High-End

5-Year PE Range -455x~0x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

-69.7x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks are extreme. Oklo is a pre-revenue company burning cash at an accelerating rate, with net losses widening from -$9.81M in Q1 2025 to -$41.45M in Q4 2025. The TTM free cash flow burn of -$115.38M must be funded entirely by equity issuance, as seen with the $296.22M stock sale in Q4, leading to shareholder dilution. The company has no revenue, margins, or earnings visibility, making its financial health entirely dependent on its ability to raise capital in often-unforgiving public markets.

Market & Competitive Risks center on valuation compression and sector sentiment. Trading at a market cap of $10.5B with zero revenue, the stock carries a massive speculative premium vulnerable to a shift in investor appetite for long-duration, high-risk stories. Its beta of 0.943 is deceptively low for a speculative name, suggesting it trades on idiosyncratic news, but a broader market downturn could still trigger outflows from such assets. Competitive risks include other advanced nuclear developers and alternative clean energy technologies that may reach commercialization faster or cheaper.

The Worst-Case Scenario involves a critical regulatory denial from the NRC, a major partnership falling through, or a severe equity market closure that prevents further capital raises. This could halt development entirely, leading to a rapid devaluation. The realistic downside is severe: a retest of the 52-week low of $19.89, which would represent a -70% decline from the current price of $66.81. The stock's historical max drawdown of -73.83% provides a precedent for such a catastrophic loss of value.

FAQ

The key risks are, in order of severity: 1) Binary Regulatory Risk: Failure to secure final NRC approval could render the company worthless. 2) Financial Risk: The company burns over $115M annually with no revenue, requiring continuous dilutive equity raises; quarterly net losses widened to -$41.45M in Q4 2025. 3) Execution & Timeline Risk: Commercial operation is likely years away (post-2030), during which technology, cost, or partner risks could emerge. 4) Market Risk: The stock's 52-week high is $193.84 and its low is $19.89, demonstrating extreme volatility and sentiment dependency.

The 12-month forecast is highly volatile and scenario-dependent. Our base case (50% probability) sees the stock trading between $50 and $80 as it oscillates on regulatory news without a fundamental catalyst. The bull case (20% probability), driven by a final license approval, could propel shares to $120-$150. The bear case (30% probability), involving a setback, could see a collapse toward $20-$40, retesting the 52-week low. The most likely outcome is the base case, as the lengthy regulatory process suggests no transformative revenue news within the year.

OKLO is dramatically overvalued by any conventional fundamental metric, as it has no revenue, negative earnings, and trades at a trailing P/B of 7.11x. The market is pricing in near-perfect execution of a long-dated business plan. Based on a distant analyst revenue estimate of $315.3M, the implied forward P/S is ~33.3x, a premium typically reserved for high-growth software, not capital-intensive utilities. The valuation implies the market expects successful commercialization, rapid scaling, and significant future profits, leaving no margin for error.

OKLO is not a 'good buy' in the traditional sense of a financially sound company at a reasonable price. It is a highly speculative warrant on future success. For investors with a high risk tolerance, a long time horizon (5+ years), and a portfolio structured to absorb total loss, it offers asymmetric upside if its technology is commercialized. However, given its $10.5B valuation on zero revenue, -$115M annual cash burn, and -59% six-month return, it is a poor choice for most retail investors seeking capital preservation or income.

OKLO is strictly a long-term, speculative investment with a minimum horizon of 5-7 years, aligning with its potential commercialization timeline. It is wholly unsuitable for short-term trading or income-seeking investors. The stock's beta of 0.943 and recent 17.83% monthly surge show it can have sharp rallies, but these are driven by news sentiment, not fundamentals, making short-term timing exceptionally difficult. The absence of dividends and the certainty of future dilution further negate any short-term holding rationale.